Intratumoural heterogeneity is often an obstacle for accurate assessment of tumour profiles and determining treatment strategy.5 We hypothesised that PD-L1 expression evaluated by biopsy samples might differ from PD-L1 expression in the whole tumour because of intratumoural heterogeneity. The gene discussed is CD274; the disease is neoplasm.